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A 15-year-old female presented to the emergency department with complaints of vaginal bleeding. 
She was pale, anxious, cool and clammy with tachycardic, thready peripheral pulses and hemoglobin 
of 2.4g/dL. Her abdomen was gravid appearing, approximately early to mid-second trimester in size. 
Pelvic examination revealed 2 cm open cervical os with spontaneous discharge of blood, clots and 
a copious amount of champagne-colored grapelike spongy material. After 2L boluses of normal 
saline and two units of crossmatched blood, patient was transported to the operating room. Surgical 
pathology confirmed a complete hydatidiform mole. 
[West J Emerg Med. 2009;10(4):295-296.]
CASE REPORT
A 15-year-old female patient presented via emergency 
medical services to the ED with complaints of vaginal 
bleeding and weakness. The patient had been bleeding for the 
past seven days and had mild cramping abdominal pain. She 
admitted to sexual activity but was unsure if she was pregnant. 
She believed her last menstrual period was approximately one 
month prior. Her past medical history and family history were 
unremarkable. She denied allergies to medications, smoking, 
drinking alcohol or any drug use. 
The patient was alert and oriented and in obvious distress. 
She was pale, anxious, and weak. Her temperature was 98.2˚F, 
blood pressure 129/64mmHg, heart rate 133bpm, respiratory 
rate of 16 breaths per min with a pulse oximetry of 100% on 
supplemental oxygen. On physical exam she was cool and 
clammy with mildly labored breathing. She was tachycardic 
with thready peripheral pulses and no murmurs. Her abdomen 
was gravid appearing, approximately early to mid-second 
trimester in size. She was soft and mildly tender to palpation 
in the lower quadrants bilaterally. Her lower extremities were 
nontender and moderately edematous. Pelvic examination 
revealed spontaneous discharge of blood, clots and a copious 
amount of champagne-colored grapelike spongy material. No 
fetal parts were identifiable (Figure 1). The cervical os was 
open to approximately 2cm with moderate cervical motion 
tenderness.
ED laboratory results showed hemoglobin of 2.4 g/dL, 
hematocrit of 7.3%, white blood count at 16,700 with 74% 
neutrophils and 4% bands, platelets at 133,000, international 
normalized ratio of 1.3, and bicarbonate of 12 mmol/L. Bun 
was elevated at 36 mg/dL and creatinine was 0.6 mg/dL. 
Free T4 was 2.79 ng/dL (normall range: 0.93-1.7) and TSH 
was 0.01 mcu/mL (normal range: 0.27-4.2). Beta HCG was 
460,318 mIU/mL, 64 times the upper limit of normal for an 
estimated gestational age of a five-week fetus. EKG revealed 
sinus tachycardia. 
Obstetrics was emergently consulted and the patient 
transported urgently to the operating room for dilation and 
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curettage. While in the ED, the patient received 2L boluses 
of normal saline and two units of crossmatched blood. 
Surgical pathology confirmed a complete hydatidiform mole. 
The patient suffered postoperative complications including 
respiratory distress requiring intubation, cardiomyopathy 
(ejection fraction of 25%) and hyperthyroidism. She was 
medically managed in the intensive care unit and discharged 
one week later with improved ejection fraction, recovering 
thyroid function and no evidence of malignant gestational 
trophoblastic disease.
DISCUSSION
Hydatidiform mole (molar pregnancy) is a relatively rare 
complication of fertilization with an incidence in the United 
States of 0.63 to 1.1 per 1000 pregnancies, although rates vary 
geographically.1 It is included in the spectrum of gestational 
trophoblastic diseases and is comprised of both complete 
molar pregnancies (CM) and partial molar pregnancies (PM). 
Pathologically, CM demonstrate diffuse villous edema and 
trophoblastic proliferation with absence of a fetus, whereas 
with PM villous edema and trophoblastic proliferation are 
variable and the fetus typically demonstrates congenital 
abnormalities and growth retardation.2
The most well characterized risk factor for CM is extreme 
of maternal age. Maternal ages less than 20 or greater than 40 
years have been associated with relative risks for CM as high 
as 10- and 11-fold greater respectively.3,4 However, the majority 
of molar pregnancies occur within the 20-40 year range, as 
these represent the most common reproductive years. History 
of prior molar pregnancy is another important risk factor for 
both CM and PM, with repeat molar pregnancies occurring 0.6 
to 2.6 percent of the time.1 Other potential risk factors include 
oral contraceptive use, maternal type A or AB blood groups, 
maternal smoking, and maternal alcohol abuse.1,3
Molar pregnancy typically presents in the first trimester 
and may be associated with a wide array of findings, including 
vaginal bleeding (most common), uterine size larger than 
expected according to pregnancy date (CM), uterine size 
smaller than expected according to pregnancy date (PM), 
excessive beta-human chorionic gonadotropin (β-hcg) levels, 
anemia, hyperemesis gravidum, theca lutein cysts, pre-
eclampsia, and respiratory distress.2,5,6 β-hcg is a glycoprotein 
hormone structurally similar to thyroid-stimulating hormone, 
and for this reason many patients will present with clinical 
hyperthyroidism.7 This patient’s peripheral edema is most 
likely related to her significant peripartum cardiomyopathy, 
although differential diagnosis also includes preeclampsia, 
hyperthryoidism, high output failure, or a hypoalbuminemic 
state. Studies comparing modern clinical presentations 
of CM with historical presentations have demonstrated a 
significant reduction in many of the classic presenting signs 
and symptoms such as vaginal bleeding and excessive uterine 
size.8,9,10 This reduction is attributed to early detection by 
transvaginal ultrasound and increasingly sensitive β-hcg 
assays. Numerous studies evaluating the efficacy of ultrasound 
in detecting molar pregnancy demonstrate a 57-95 percent 
sensitivity for the detection of CM compared to only 18-49 
percent sensitivity for PM.11
This case is of particular interest due to its late 
presentation and classic features. It is unusual for this type of 
patient to expel diagnostic tissue in the ED, and it serves as a 
reminder that patients who delay medical attention may not 
present as expected. 
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